SE9904404L - Ny komposition - Google Patents

Ny komposition

Info

Publication number
SE9904404L
SE9904404L SE9904404A SE9904404A SE9904404L SE 9904404 L SE9904404 L SE 9904404L SE 9904404 A SE9904404 A SE 9904404A SE 9904404 A SE9904404 A SE 9904404A SE 9904404 L SE9904404 L SE 9904404L
Authority
SE
Sweden
Prior art keywords
new composition
composition
new
pharmaceutical compositions
paroxetine methanesulfonate
Prior art date
Application number
SE9904404A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9904404D0 (sv
Inventor
David Philip Elder
Ahmad Khalaf Al Deeb A Ghazawi
Nee Patel Padma Menaeud
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SE9904404D0 publication Critical patent/SE9904404D0/xx
Publication of SE9904404L publication Critical patent/SE9904404L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9904404A 1999-06-22 1999-12-03 Ny komposition SE9904404L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
SE9904404D0 SE9904404D0 (sv) 1999-12-03
SE9904404L true SE9904404L (sv) 2000-12-23

Family

ID=27269749

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904404A SE9904404L (sv) 1999-06-22 1999-12-03 Ny komposition

Country Status (21)

Country Link
EP (1) EP1064936A1 (no)
AT (1) AT3722U1 (no)
AU (2) AU1573100A (no)
BE (2) BE1013166A6 (no)
CA (1) CA2291542A1 (no)
CH (1) CH690024A5 (no)
DE (2) DE19958228A1 (no)
DK (2) DK199901730A (no)
ES (1) ES2159260B1 (no)
FI (2) FI4488U1 (no)
FR (1) FR2795327A1 (no)
GB (1) GB2351233A (no)
GR (1) GR1003490B (no)
IE (2) IES991108A2 (no)
IT (1) ITMI992549A1 (no)
LU (1) LU90483B1 (no)
NL (2) NL1013750C1 (no)
NO (1) NO995945L (no)
PT (1) PT102384A (no)
SE (1) SE9904404L (no)
WO (1) WO2000078291A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
HUP0303827A2 (hu) * 2000-08-28 2004-04-28 Synthon B.V. Paroxetinkészítmények és eljárások ezek előállítására
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
EP1469829B1 (en) 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
WO2005010002A1 (en) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009281A2 (en) * 1990-11-24 1992-06-11 Beecham Group Plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
EP1064936A1 (en) 2001-01-03
ES2159260A1 (es) 2001-09-16
AT3722U1 (de) 2000-07-25
FR2795327A1 (fr) 2000-12-29
DE29921300U1 (de) 2000-02-10
AU1573100A (en) 2001-01-09
FI19992609A (fi) 2000-12-22
SE9904404D0 (sv) 1999-12-03
GB9928673D0 (en) 2000-02-02
ES2159260B1 (es) 2002-05-01
CA2291542A1 (en) 2000-12-22
LU90483B1 (fr) 2001-01-31
WO2000078291A1 (en) 2000-12-28
PT102384A (pt) 2000-12-29
IES991108A2 (en) 2001-04-04
NO995945L (no) 2000-12-27
FIU990494U0 (fi) 1999-12-03
BE1013166A6 (fr) 2001-10-02
AU727000B3 (en) 2000-11-30
DK199901730A (da) 2000-12-23
FI4488U1 (fi) 2000-07-20
ITMI992549A1 (it) 2001-06-03
NL1013750C1 (nl) 2000-12-28
DE19958228A1 (de) 2000-12-28
GB2351233A (en) 2000-12-27
IE991107A1 (en) 2001-05-30
NL1013749C2 (nl) 2001-01-08
DK199900435U3 (da) 2000-02-11
BE1012806A3 (fr) 2001-03-06
CH690024A5 (fr) 2000-03-31
NO995945D0 (no) 1999-12-03
GR1003490B (el) 2000-11-30
ITMI992549A0 (it) 1999-12-03

Similar Documents

Publication Publication Date Title
FI991485A (fi) Uusi farmaseuttinen koostumus
NO20021116D0 (no) Ny sammensetning
NO20025450L (no) Ny farmasöytisk sammensetning
EA199900373A3 (ru) Фармацевтические композиции
PT1242087E (pt) Composicoes farmaceuticas
NO20015175D0 (no) Farmasöytisk sammensetning
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
EE201000020A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
PT1165069E (pt) Composicao sinergistica antitumoral
AR023440A1 (es) Composiciones antitranspirantes
DK200000390U1 (da) Farmaceutiske præparater til oral indgivelse, der omfatter paroxetin-methansulfonat.
NO20021115L (no) Ny sammensetning
ID29785A (id) Komposisi-komposisi sampo
DE60010547D1 (de) Vernetzbare Fluoropolyetherzusammensetzungen
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE69931821D1 (de) Wärmehärtbare pulverlack-zusammensetzung
NO993460D0 (no) Paroxetine-preparater
SE9904404L (sv) Ny komposition
DE60036959D1 (de) Tensidzusammensetzungen, verbesserungsmittel enthaltend
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
EE04217B1 (et) Farmatseutilised kompositsioonid
FI20012140A (fi) Uudet kvaternääriset yhdisteet, niitä sisältävät koostumukset ja niiden käyttöjä
NO20005681D0 (no) Nye formuleringer som inneholder paroxetin
DZ2853A1 (fr) Composition anthelminthique non aqueuse
NO20005683D0 (no) Ny formulering inneholdende paroxetin

Legal Events

Date Code Title Description
NAV Patent application has lapsed